Undoubtedly, metallomic approaches based on mass spectrometry have evolved into essential tools supporting the drug development of novel metal-based anticancer drugs. This article will comment on the state-of-the-art instrumentation and highlight some of the recent analytical advances beyond routine, especially focusing on the latest developments in inductively coupled plasma-mass spectrometry (ICP-MS). Mass spectrometry-based bioimaging and single-cell methods will be presented, paving the way to exciting investigations of metal-based anticancer drugs in heterogeneous and structurally, as well as functionally complex solid tumor tissues.
Keywords: Imaging mass spectrometry; Laser ablation-ICP-MS; Metallodrug development; Metallomics; Single-cell analysis.
Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved.